J P Ducret
Overview
Explore the profile of J P Ducret including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ducret J, Ponchon D, Charpentier J, Brun P
Med Trop (Mars)
. 2001 Oct;
61(1):21-6.
PMID: 11584652
Management and treatment of disease do not always conform with official recommendations. African-quin is a pragmatic multicentric study carried out in 13 African countries to evaluate non-conformities in the management...
2.
Same-Ekobo A, Lohoue J, Essono E, Ravinet L, Ducret J
Med Trop (Mars)
. 1999 Sep;
59(1):43-5.
PMID: 10472581
This randomized, non-comparative clinical trial without placebo was carried out to assess the efficacy and tolerance of artesunate for treatment of acute Plasmodium ovale malarial attacks. Thirty Cameroonese patients were...
3.
Moneton P, Ducret J
Med Trop (Mars)
. 1999 Apr;
58(3 Suppl):70-2.
PMID: 10212905
Sanofi decided, some years ago, to help developing a molecule of a new type called artesunate, a semisynthetic derivative from Qinghaosu, or artemisinine, a sesquiterpenic lactone extracted from the leaves...
4.
Carel J, Mathivon L, Gendrel C, Ducret J, Chaussain J
J Clin Endocrinol Metab
. 1998 May;
83(5):1462-6.
PMID: 9589639
An adapted GH dose regimen was evaluated in 14 untreated patients with Turner's syndrome. The initial GH dose (0.7 U/kg.BW) was increased by 0.7 U/kg.BW, up to a maximum of...
5.
Job J, Chaussain J, Job B, Ducret J, Maes M, Olivier M, et al.
Pediatr Res
. 1996 Feb;
39(2):354-9.
PMID: 8825812
Seventy-eight prepubertal, non-GH-deficient children aged 8.1 +/- 0.2 y, with very short stature (mean, -3.2 SD) of intrauterine onset, were treated for 3 y with GH [0.4 (dose D1) or...
6.
Chatelain P, Job J, Blanchard J, Ducret J, Oliver M, Sagnard L
J Clin Endocrinol Metab
. 1994 Jun;
78(6):1454-60.
PMID: 8200949
This study reports the results of a 2-yr clinical trial with GH in 95 short prepubertal children with non-GH-deficient intrauterine growth retardation. This randomized, double blind, controlled study compared the...
7.
Adult height in children with prepubertal short stature secondary to intrauterine growth retardation
Chaussain J, Colle M, Ducret J
Acta Paediatr Suppl
. 1994 Apr;
399:72-3.
PMID: 7949621
In a retrospective study of 47 children seen before puberty for growth retardation secondary to intrauterine growth retardation (IUGR), 23 boys had a final height of 161.9 +/- 8.0 cm...
8.
Porneuf M, Ducret J, Bonvalet D, Perrin P, Duterque M
Ann Dermatol Venereol
. 1993 Jan;
120(11):824-7.
PMID: 8210133
No abstract available.
9.
Colle M, Sagnard L, Ducret J, Auzerie J
Horm Res
. 1990 Jan;
34(5-6):204-8.
PMID: 2100276
In order to investigate the value of growth hormone (GH) treatment during late puberty, we studied the effect of human GH (hGH) administration (0.85 +/- 0.30 IU/kg/week; range: 0.44-1.28) on...
10.
Bonvalet D, Duterque M, Ducret J
Ann Dermatol Venereol
. 1988 Jan;
115(11):1186-8.
PMID: 3239912
No abstract available.